BRPI0718307A2 - Uso de oligossacarídeos indigeríveis, composição nutricional, oligossacarídeos indigeríveis, e, método para melhora de resistência à insulina, prevenção da queda glicêmica pós-prandial e/ou diminuição da resposta à glicose pós-prandial de uma refeição - Google Patents

Uso de oligossacarídeos indigeríveis, composição nutricional, oligossacarídeos indigeríveis, e, método para melhora de resistência à insulina, prevenção da queda glicêmica pós-prandial e/ou diminuição da resposta à glicose pós-prandial de uma refeição

Info

Publication number
BRPI0718307A2
BRPI0718307A2 BRPI0718307-0A2A BRPI0718307A BRPI0718307A2 BR PI0718307 A2 BRPI0718307 A2 BR PI0718307A2 BR PI0718307 A BRPI0718307 A BR PI0718307A BR PI0718307 A2 BRPI0718307 A2 BR PI0718307A2
Authority
BR
Brazil
Prior art keywords
response
indigestible oligosaccharides
glandose
prevention
post
Prior art date
Application number
BRPI0718307-0A2A
Other languages
English (en)
Inventor
Houkje Bouritius
Laere Katrien Maria Jozefa Van
Robert Johan Joseph Hageman
De Heijning Hubertus Josephus Van
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of BRPI0718307A2 publication Critical patent/BRPI0718307A2/pt
Publication of BRPI0718307B1 publication Critical patent/BRPI0718307B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pediatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
BRPI0718307-0A 2006-11-02 2007-11-02 uso de oligossacarídeos indigeríveis e composições nutricionais BRPI0718307B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/NL2006/050275 WO2008054193A1 (en) 2006-11-02 2006-11-02 Nutritional products that comprise saccharide oligomers
NLPCT/NL2006/050275 2006-11-02
PCT/NL2007/050530 WO2008054211A1 (en) 2006-11-02 2007-11-02 Nutritional products comprising saccharide oligomers

Publications (2)

Publication Number Publication Date
BRPI0718307A2 true BRPI0718307A2 (pt) 2014-04-29
BRPI0718307B1 BRPI0718307B1 (pt) 2020-11-17

Family

ID=38134585

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0718307-0A BRPI0718307B1 (pt) 2006-11-02 2007-11-02 uso de oligossacarídeos indigeríveis e composições nutricionais

Country Status (17)

Country Link
US (1) US8637487B2 (pt)
EP (1) EP2086353B1 (pt)
JP (1) JP2010515665A (pt)
CN (1) CN101626696B (pt)
AU (1) AU2007314732A1 (pt)
BR (1) BRPI0718307B1 (pt)
CA (1) CA2668312C (pt)
DK (1) DK2086353T3 (pt)
ES (1) ES2714575T3 (pt)
HU (1) HUE042644T2 (pt)
IL (1) IL198517A0 (pt)
MX (1) MX2009004814A (pt)
PL (1) PL2086353T3 (pt)
RU (1) RU2469557C2 (pt)
TR (1) TR201903494T4 (pt)
WO (2) WO2008054193A1 (pt)
ZA (1) ZA200903497B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
ES2547122T5 (es) 2009-01-19 2019-11-04 Nutri Co Ltd Composición nutricional de baja concentración
WO2010098822A1 (en) 2009-02-24 2010-09-02 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
WO2010104374A1 (en) * 2009-03-09 2010-09-16 N.V. Nutricia Nutritional composition inducing a postprandial endocrine response
JP6077303B2 (ja) * 2009-05-07 2017-02-08 タト エ リル アングルディアント フランス ソシエテ パ アクシオンス シンプリフィエ アルファ−(1,2)−分岐アルファ−(1,6)オリゴデキストランを含有する組成物及びアルファ−(1,2)−分岐アルファ−(1,6)オリゴデキストランの製造方法
IT1399244B1 (it) * 2009-07-31 2013-04-11 Pharmarte S R L Formulazione di barretta specifica per la gravidanza.
US8617636B2 (en) * 2009-10-01 2013-12-31 Roquette Freres Carbohydrate compositions having a greater impact on the insulinemic response than on the glycemic response, their preparation and their uses
WO2011137249A1 (en) 2010-04-28 2011-11-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
DE102011012494A1 (de) * 2011-02-25 2012-08-30 Humana Milchunion Eg Prebiotische Kohlenhydrat-Zusammensetzungen
GB2492559B (en) * 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
CN103889240B (zh) * 2011-10-18 2016-09-14 雀巢产品技术援助有限公司 用于增加胰岛素敏感性和/或降低胰岛素抵抗性的组合物
JP5927663B2 (ja) 2011-10-21 2016-06-01 松谷化学工業株式会社 血糖値の上昇が緩やかな糖質組成物及び飲食品
US10190142B2 (en) * 2016-01-25 2019-01-29 King-Prebiotics Biotechnology (Tw) Co., Ltd. High-purity galactooligosaccharide compositions, preparations, and applications thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2097041C1 (ru) * 1994-11-22 1997-11-27 Чепурной Иван Петрович Способ лечения сахарного диабета
ATE362715T1 (de) * 1997-06-23 2007-06-15 Nestle Sa Zusammensetzung zur ernährung von diabetikern
ATE270822T1 (de) 1999-05-20 2004-07-15 Nestle Sa Verfahren zur erhöhung der propionateproduktion im gastrointestinaltrakt
DE19961182B4 (de) * 1999-12-18 2006-01-12 Südzucker AG Mannheim/Ochsenfurt Galactomannan-Oligosaccharide und Verfahren zu deren Herstellung sowie deren Verwendung
US6774111B1 (en) * 2000-03-14 2004-08-10 Abbott Laboratories Carbohydrate system and a method for providing nutrition to a diabetic
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
JP2002306131A (ja) * 2001-04-16 2002-10-22 Takara Bio Inc 食品、飲料又は飼料
CN1164186C (zh) * 2001-04-29 2004-09-01 上海光明乳业股份有限公司 益菌奶及其制造方法
AU2002303860A1 (en) * 2001-05-31 2002-12-09 Abbott Laboratories Acid controlled viscosity fiber system and uses thereof
US6989166B2 (en) * 2001-12-20 2006-01-24 N.V. Nutricia Soft drink replacer
JP4401659B2 (ja) 2002-02-04 2010-01-20 協和発酵バイオ株式会社 インスリン分泌促進剤
EP1332759B1 (en) 2002-02-04 2005-09-28 Kyowa Hakko Kogyo Co., Ltd. Pharmaceutical and nutritional compositions containing a di- or oligosaccharide as insulin secretion promoter
JP4328490B2 (ja) * 2002-03-01 2009-09-09 天野エンザイム株式会社 飲食品の風味改善剤及びこれが添加された食品並びに飲食品の風味改善方法
EP1514551A4 (en) * 2002-05-31 2008-01-09 Amano Enzyme Inc ANTI-INFLAMMATORY, AGENT TO COMBAT ALLERGIC DISEASES, AND FUNCTIONAL FOOD
FR2844453B1 (fr) 2002-09-13 2006-05-19 Agronomique Inst Nat Rech Utilisation de pre-biotiques pour la prevention de l'installation du diabete de type ii
JP2004149471A (ja) * 2002-10-31 2004-05-27 Shiratori Pharmaceutical Co Ltd 血糖低下剤
PT1675481E (pt) * 2003-10-24 2009-01-02 Nutricia Nv Composição sinbiótica para bebés
CN1545937A (zh) * 2003-12-03 2004-11-17 上海交大昂立股份有限公司 一种含有益生元的儿童保健食品及其制备方法
NZ552706A (en) 2004-07-19 2011-01-28 Nutricia Nv Use of aspartate for regulating glucose levels in blood
ATE361101T1 (de) * 2004-08-24 2007-05-15 Nutricia Nv Nahrungszusammensetzung die unverdauliche oligosaccharide enthält
CN1332619C (zh) * 2004-09-20 2007-08-22 段治义 魔芋低聚糖快速减肥食品及其制作方法
EP1656839A1 (en) * 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
ES2419205T3 (es) * 2005-04-06 2013-08-19 Nestec S.A. Composición para mejorar la regulación de la glicemia y la acción de la insulina, por vía nutritiva

Also Published As

Publication number Publication date
PL2086353T3 (pl) 2019-05-31
CN101626696A (zh) 2010-01-13
CN101626696B (zh) 2016-01-20
AU2007314732A1 (en) 2008-05-08
ES2714575T3 (es) 2019-05-29
US8637487B2 (en) 2014-01-28
CA2668312C (en) 2015-08-25
HUE042644T2 (hu) 2019-07-29
TR201903494T4 (tr) 2019-04-22
MX2009004814A (es) 2009-07-17
ZA200903497B (en) 2010-05-26
DK2086353T3 (en) 2019-03-25
EP2086353A1 (en) 2009-08-12
CA2668312A1 (en) 2008-05-08
JP2010515665A (ja) 2010-05-13
US20100069327A1 (en) 2010-03-18
WO2008054211A9 (en) 2008-10-16
BRPI0718307B1 (pt) 2020-11-17
IL198517A0 (en) 2010-02-17
RU2009120697A (ru) 2010-12-10
EP2086353B1 (en) 2018-12-12
WO2008054193A1 (en) 2008-05-08
RU2469557C2 (ru) 2012-12-20
WO2008054211A1 (en) 2008-05-08

Similar Documents

Publication Publication Date Title
BRPI0718307A2 (pt) Uso de oligossacarídeos indigeríveis, composição nutricional, oligossacarídeos indigeríveis, e, método para melhora de resistência à insulina, prevenção da queda glicêmica pós-prandial e/ou diminuição da resposta à glicose pós-prandial de uma refeição
BRPI0816097A2 (pt) composição farmacêutica, método para tratar eritema em um paciente com rosácea, e, uso de uma composição.
BRPI0820967A2 (pt) Uso de uma composição, composição farmacêutica e método para tratamento, melhora ou profilaxia dos sintomas de uma doença inflamatória
EP2016056A4 (en) IONIC VISCOELASTIC AND VISCOELASTIC SALTS
BRPI0918139A2 (pt) composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso
BRPI0816133A2 (pt) Composição que emite flavorizante, dispositivo que emite flavorizante, tablete comprimido ou moldado, produto alimentício acondicionado, e, métodos para fabricar um dispositivo que emite flavorizante e uma composição que emite flavorizante.
IL190206A0 (en) Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome
WO2009051706A3 (en) Peptide compounds for treating obesity and insulin resistance
GB0502042D0 (en) Materials and methods for diagnosis and treatment of chronic fatigue syndrome
WO2007112069A3 (en) Endothelin and endothelin receptor agonists in the treatment of metabolic diseases
BRPI1009381A2 (pt) compostos, composição farmacêutica, método para tratar doença ou condição associada com função de trap1 em sujeito em necessidade do mesmo e uso de compostos e composição farmacêutica
BRPI0719250A2 (pt) Métodos e composições com opalescência reduzida.
FI20060501L (fi) Koostumus ja menetelmä asetaldehydin sitomiseksi vatsassa
DK2227539T3 (da) Sammensætning til menneske- og/eller dyreernæring, anvendelser deraf og gær
BRPI0720604A2 (pt) Composição e método para detecção de desmineralização
IL196965A (en) Analogues of (r, r) or (s, r) phenoterol, their pharmaceutical composition containing them and their use for the treatment of heart failure
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
HUS1800034I1 (hu) Anti-FGF23 ellenanyag és anti-FGF23 ellenanyagot tartalmazó gyógyászati készítmény
BRPI0917728A2 (pt) composição, uso da composição, e, método de prevenção da formação de espuma em uma composição
BRPI0719272A2 (pt) Composição de enzima, e, método para preparar uma composição de enzima.
IL196136A (en) Its aminoindane or salt derivative, the pharmaceutical composition containing them and their uses
DK1986611T3 (da) Proteinpolymernanopartikler med repeat-sekvens, der eventuelt indeholder aktive stoffer, og fremstilling heraf
IL206767A0 (en) B cell depleting antibodies, or fragments thereof, compositions comprising the same and use thereof for treating chronic fatigue syndrome
BRPI0615746A2 (pt) composição, e, método para inibir ou impedir o crescimento biológico em uma composição
WO2007120156A3 (en) Animal models of long qt syndrome and uses thereof

Legal Events

Date Code Title Description
B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A23L 1/29; A61P 3/10.

Ipc: A23L 33/21 (2016.01), A23L 33/10 (2016.01), A23L 3

Ipc: A23L 33/21 (2016.01), A23L 33/10 (2016.01), A23L 3

B15K Others concerning applications: alteration of classification

Ipc: A23L 33/21 (2016.01), A23L 33/10 (2016.01), A23L 3

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/11/2020, OBSERVADAS AS CONDICOES LEGAIS.